查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1916651

全球肠脑轴及情绪改善型快速消费品市场预测（至2032年），依产品类型、成分、通路、最终用户及地区划分

Gut-Brain Axis & Mood-Enhancing FMCG Market Forecasts to 2032 - Global Analysis By Product Type (Functional Beverages, Functional Foods, Dietary Supplements, and Other Product Types), Ingredient, Distribution Channel, End User, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的研究，全球肠脑轴和情绪增强快速消费品市场预计到 2025 年将达到 134.3 亿美元，到 2032 年将达到 222.9 亿美元，预测期内复合年增长率为 7.5%。

肠脑平衡和情绪改善型快速消费品是指那些透过关註消化系统健康与大脑功能之间的联繫，来促进情绪和认知健康的日常消费品。这些产品通常含有有益微生物、植物来源原和神经支持营养素等功能性成分，能够影响肠道菌丛和神经讯号传导。透过将心理健康融入日常消费，这些快速消费品提供了便利且有科学依据的选择，有助于缓解压力、改善情绪、提升专注力并增强整体心理健康。

让心理益生菌疗法成为主流

除了消化系统健康，消费者也越来越重视能够促进心理健康的功能性食品和饮料。日益增长的压力水平和文明病的增加，推动了对具有改善情绪功效产品的需求。越来越多的科学证据表明，益生菌和益生元能够调节神经传导物质，这增强了消费者的信心。快速消费品公司正在加大研发投入，将益生菌融入日常消费品中。行销宣传活动强调整体健康，并将肠道健康定位为情绪健康的关键。这一主流趋势正在重塑产品系列，并在已开发市场和新兴市场都得到更广泛的应用。

原料成本上涨

特殊的益生菌菌株和生物活性化合物需要先进的培养和保存技术。这些製程会增加生产成本，限制中小企业扩大生产规模。高成本也阻碍了产品的普及，减缓了其在价格敏感型市场的渗透。此外，遵守安全性和有效性法规也会带来额外的经济负担。为了保持竞争力，企业必须在创新和成本效益之间取得平衡。如果成本控制方面没有突破性进展，高价策略可能会阻碍情绪改善型快速消费品的广泛普及。

超个性化

消费者越来越关注能够满足其个人情绪和健康需求的客製化营养解决方案。微生物组检测和人工智慧驱动的分析技术的进步使得个人化产品提案成为可能。品牌正在利用数位平台提供个人化的订阅模式。这种趋势透过根据个人健康状况调整产品，提高了消费者的参与度和忠诚度。高度个人化也有助于提升品牌的高端定位，使企业在竞争激烈的市场中脱颖而出。

供应链不稳定

由于高度依赖特殊原料，肠脑轴快速消费品产业极易受到供应链中断的影响。益生菌菌株和功能性植物成分通常需要在受控环境下生产，并需要全球采购，而物流不稳定、原材料短缺和地缘政治紧张局势都可能导致生产延误。疫情相关的限制措施凸显了原料供应链的脆弱性。企业正在采用数位监控和预测分析来降低风险。然而，持续的波动性威胁着库存稳定性和产品的及时上市。

新冠疫情的影响：

疫情改变了消费者的优先事项，并加速了对提升情绪的快速消费品的需求。封锁期间加剧的压力和焦虑促使人们对益生菌和机能饮料的兴趣增加。供应链中断最初限制了供应，导致短期短缺。然而，这场危机也推动了电子商务和直销管道的创新。品牌在行销中强调免疫力和心理健康，以应对疫情引发的健康问题。监管机构推出了灵活的指导方针，以支援产品核可。后疫情时代的策略重点在于增强韧性、数位互动以及在整个快速消费品价值链中实现整体健康定位。

预计在预测期内，机能饮料细分市场将占据最大的市场份额。

预计在预测期内，机能饮料将占据最大的市场份额。这些产品为消费者提供了一种便捷的方式来摄取益生菌和情绪改善成分。消费者对即饮型产品的偏好日益增长，推动了该细分市场的扩张。口味、包装和保质期方面的创新提升了其吸引力。机能饮料正逐渐被推广为日常健康习惯，而非偶尔服用的补充剂。零售和线上通路的便利供应也增强了其市场渗透率。

预计在预测期内，缓解压力和焦虑细分市场将实现最高的复合年增长率。

预计在预测期内，缓解压力和焦虑的产品细分市场将实现最高成长率。全球范围内不断上升的压力水平正在推动消费者对针对性情绪改善解决方案的需求。益生菌和适应原正被添加到快速消费品中，以改善情绪健康。支持其功效的科学证据正在提升消费者的信任度。年轻一代，尤其是千禧世代和Z世代，正在将这些产品用于生活方式管理。数位化健康平台正在提高人们对这些产品的认知度和可及性。

占比最大的地区：

预计亚太地区将在预测期内占据最大的市场份额，因为可支配收入的成长和健康意识的提高正在推动对功能性产品的需求。中国、印度和日本等国家正在投资以健康为导向的日常消费品（FMCG）创新。该地区的传统饮食习惯与益生菌和草药配方天然契合。政府促进本地生产的措施正在加强供应链。快速的都市化加剧了人们的压力，进一步推动了对改善情绪的消费品的需求。

复合年增长率最高的地区：

预计北美地区在预测期内将实现最高的复合年增长率，这得益于强劲的研发投入和技术领先优势，从而推动了益生菌领域的快速创新。美国和加拿大正在引领个人化营养和基于微生物组的解决方案。法规结构也在不断改进，以简化功能性成分的核准。消费者对心理健康的高度关注正在推动改善情绪的快速消费品（FMCG）的普及。强大的电子商务基础设施正在扩大产品的可及性和分销范围。

免费客製化服务：

购买此报告的客户可以选择以下免费自订选项之一：

  • 公司概况
    • 对其他市场参与者（最多 3 家公司）进行全面分析
    • 主要参与者（最多3家公司）的SWOT分析
  • 区域细分
    • 根据客户要求，提供主要国家的市场估算和预测以及复合年增长率（註：可行性需确认）。
  • 竞争标竿分析
    • 根据主要参与者的产品系列、地理覆盖范围和策略联盟进行基准分析

目录

第一章执行摘要

第二章 前言

  • 概括
  • 相关利益者
  • 调查范围
  • 调查方法
  • 研究材料

第三章 市场趋势分析

  • 司机
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 终端用户分析
  • 新兴市场
  • 新冠疫情的感染疾病

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球肠脑轴与情绪改善类快速消费品市场（依产品类型划分）

  • 机能饮料
    • 益生菌饮料
    • 益生元饮料
    • 适应原和植物饮料
  • 机能性食品
    • 点心棒
    • 谷物/早餐
    • 发酵食品
  • 营养补充品
    • 益生菌
    • 益生元
    • 合益素
    • 改善情绪的营养补充品
  • 其他的

6. 全球肠脑轴与情绪改善快速消费品市场（依成分划分）

  • 膳食纤维
  • 适应原草药萃取物
  • 胺基酸和神经营养素
  • 维生素和矿物质
  • 其他的

7. 全球肠脑轴与情绪改善类快速消费品市场（依通路划分）

  • 超级市场和大卖场
  • 药局和保健食品店
  • 线上零售
  • DTC订阅
  • 其他的

8. 全球肠脑轴和情绪改善快速消费品市场（依最终用户划分）

  • 消化器官系统健康
  • 减轻压力和焦虑
  • 睡眠品质改善
  • 认知功能
  • 整体情绪健康
  • 其他的

9. 全球肠脑轴与情绪改善快速消费品市场（依地区划分）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 亚太其他地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美国家
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十章：重大进展

  • 协议、伙伴关係、合作和合资企业
  • 併购
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十一章 企业概况

  • Nestle SA
  • Olipop, Inc.
  • Danone SA
  • Seed Health
  • PepsiCo, Inc.
  • BioGaia AB
  • Yakult Honsha Co., Ltd.
  • Cargill, Incorporated
  • Abbott Laboratories
  • General Mills, Inc.
  • Chr. Hansen Holding A/S
  • Unilever PLC
  • Kerry Group plc
  • BASF SE
  • DuPont de Nemours, Inc.
Product Code: SMRC33224

According to Stratistics MRC, the Global Gut-Brain Axis & Mood-Enhancing FMCG Market is accounted for $13.43 billion in 2025 and is expected to reach $22.29 billion by 2032 growing at a CAGR of 7.5% during the forecast period. Gut-Brain Axis & Mood-Enhancing FMCG encompasses everyday consumer products that promote emotional and cognitive health by targeting the connection between digestive health and brain function. Such products typically feature functional ingredients like beneficial microbes, plant-based adaptogens, and neuro-supportive nutrients that influence gut microbiota and neural signaling. By integrating mental wellness into routine consumption, these FMCG offerings provide accessible, science-backed options to help manage stress, improve mood, support focus, and enhance overall psychological well-being.

Market Dynamics:

Driver:

Mainstreaming of psychobiotics

Consumers are increasingly seeking functional foods and beverages that support mental well-being alongside digestive health. Rising stress levels and lifestyle disorders are accelerating demand for mood-enhancing formulations. Scientific validation of probiotics and prebiotics in regulating neurotransmitters is strengthening consumer trust. FMCG companies are investing in R&D to integrate psychobiotics into everyday consumables. Marketing campaigns emphasize holistic wellness, positioning gut health as central to emotional balance. This mainstreaming trend is reshaping product portfolios and expanding adoption across both developed and emerging regions.

Restraint:

High ingredient costs

Specialized strains of probiotics and bioactive compounds require advanced cultivation and preservation techniques. These processes increase manufacturing expenses and limit scalability for smaller firms. High costs also restrict affordability, slowing penetration into price-sensitive markets. Regulatory compliance for safety and efficacy adds further financial burden. Companies must balance innovation with cost efficiency to remain competitive. Without breakthroughs in cost reduction, premium pricing may hinder widespread adoption of mood-enhancing FMCG products.

Opportunity:

Hyper-personalization

Consumers are increasingly drawn to tailored nutrition solutions that address individual mood and wellness needs. Advances in microbiome testing and AI-driven analytics enable customized product recommendations. Brands are leveraging digital platforms to deliver personalized subscription models. This trend enhances consumer engagement and loyalty by aligning products with unique health profiles. Hyper-personalization also supports premium positioning, allowing companies to differentiate in a crowded marketplace.

Threat:

Supply chain volatility

The gut-brain axis FMCG sector is vulnerable to supply chain disruptions due to reliance on specialized ingredients. Strains of probiotics and functional botanicals often require controlled environments and global sourcing. Volatility in logistics, raw material shortages, and geopolitical tensions can delay production. Pandemic-related restrictions highlighted the fragility of ingredient supply chains. Companies are adopting digital monitoring and predictive analytics to mitigate risks. However, persistent volatility threatens inventory stability and timely product launches.

Covid-19 Impact:

The pandemic reshaped consumer priorities, accelerating demand for mood-enhancing FMCG products. Heightened stress and anxiety during lockdowns boosted interest in psychobiotics and functional beverages. Supply chain disruptions initially constrained availability, creating short-term shortages. However, the crisis also spurred innovation in e-commerce and direct-to-consumer channels. Brands emphasized immunity and mental wellness in marketing, aligning with pandemic-driven health concerns. Regulatory agencies introduced flexible guidelines to support rapid product approvals. Post-pandemic strategies now focus on resilience, digital engagement, and holistic wellness positioning across the FMCG value chain.

The functional beverages segment is expected to be the largest during the forecast period

The functional beverages segment is expected to account for the largest market share during the forecast period. These products offer convenient formats for delivering psychobiotics and mood-enhancing ingredients. Rising consumer preference for ready-to-drink solutions supports segment expansion. Innovations in flavor, packaging, and shelf stability are enhancing appeal. Functional beverages are increasingly marketed as daily wellness routines rather than occasional supplements. Their accessibility across retail and online channels strengthens market penetration.

The stress & anxiety reduction segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the stress & anxiety reduction segment is predicted to witness the highest growth rate. Rising global stress levels are driving demand for targeted mood-enhancing solutions. Psychobiotics and adaptogens are being integrated into FMCG products to address emotional well-being. Scientific evidence supporting their efficacy is boosting consumer confidence. Younger demographics, particularly millennials and Gen Z, are adopting these products for lifestyle management. Digital wellness platforms are amplifying awareness and accessibility.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to rising disposable incomes and growing health awareness are fueling demand for functional products. Countries like China, India, and Japan are investing in wellness-focused FMCG innovation. Traditional dietary practices in the region align naturally with probiotic and herbal formulations. Government initiatives promoting local production are strengthening supply chains. Rapid urbanization is increasing exposure to stress, further boosting demand for mood-enhancing consumables.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to strong R&D investment and technological leadership support rapid innovation in psychobiotics. The U.S. and Canada are pioneering personalized nutrition and microbiome-based solutions. Regulatory frameworks are evolving to streamline approvals for functional ingredients. High consumer awareness of mental health is driving adoption of mood-enhancing FMCG products. Robust e-commerce infrastructure is expanding accessibility and distribution.

Key players in the market

Some of the key players in Gut-Brain Axis & Mood-Enhancing FMCG Market include Nestle S.A., Olipop, Inc., Danone S.A., Seed Health, PepsiCo, Inc., BioGaia AB, Yakult Honsha Co., Ltd., Cargill, Incorporated, Abbott Laboratories, General Mills, Inc., Chr. Hansen Holding A/S, Unilever PLC, Kerry Group plc, BASF SE, and DuPont de Nemours, Inc.

Key Developments:

In December 2025, Mars and Cargill, announced they are spurring the development of more than 224MWac* of new renewable energy capacity through five virtual power purchase agreements (PPAs) in Poland. The PPAs were signed with GoldenPeaks Capital, one of Europe's fastest-growing independent producers of renewable energy.

In February 2025, Shedd Aquarium and global healthcare company Abbott are announcing one of Shedd's largest corporate gifts in recent history, a $10 million pledge from Abbott and Abbott's philanthropic foundation, Abbott Fund. The investment cements the longstanding partnership between Shedd, Abbott, and Abbott Fund to enrich the cultural, educational and environmental fabric of Chicago and spark passion for protecting the ocean environment.

Product Types Covered:

  • Functional Beverages
  • Functional Foods
  • Dietary Supplements
  • Other Product Types

Ingredients Covered:

  • Fibers
  • Adaptogens & Herbal Extracts
  • Amino Acids & Neuro-nutrients
  • Vitamins & Minerals
  • Other Ingredients

Distribution Channels Covered:

  • Supermarkets & Hypermarkets
  • Pharmacies & Health Stores
  • Online Retail
  • Direct-to-Consumer Subscriptions
  • Other Distribution Channels

End Users Covered:

  • Digestive Health
  • Stress & Anxiety Reduction
  • Sleep Improvement
  • Cognitive Function
  • Overall Emotional Well-being
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Gut-Brain Axis & Mood-Enhancing FMCG Market, By Product Type

  • 5.1 Introduction
  • 5.2 Functional Beverages
    • 5.2.1 Probiotic Drinks
    • 5.2.2 Prebiotic Drinks
    • 5.2.3 Adaptogen & Botanical Drinks
  • 5.3 Functional Foods
    • 5.3.1 Snack Bars
    • 5.3.2 Cereals & Breakfast Foods
    • 5.3.3 Fermented Foods
  • 5.4 Dietary Supplements
    • 5.4.1 Probiotics
    • 5.4.2 Prebiotics
    • 5.4.3 Synbiotics
    • 5.4.4 Mood-Targeted Nutraceuticals
  • 5.5 Other Product Types

6 Global Gut-Brain Axis & Mood-Enhancing FMCG Market, By Ingredient

  • 6.1 Introduction
  • 6.2 Fibers
  • 6.3 Adaptogens & Herbal Extracts
  • 6.4 Amino Acids & Neuro-nutrients
  • 6.5 Vitamins & Minerals
  • 6.6 Other Ingredients

7 Global Gut-Brain Axis & Mood-Enhancing FMCG Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Supermarkets & Hypermarkets
  • 7.3 Pharmacies & Health Stores
  • 7.4 Online Retail
  • 7.5 Direct-to-Consumer Subscriptions
  • 7.6 Other Distribution Channels

8 Global Gut-Brain Axis & Mood-Enhancing FMCG Market, By End User

  • 8.1 Introduction
  • 8.2 Digestive Health
  • 8.3 Stress & Anxiety Reduction
  • 8.4 Sleep Improvement
  • 8.5 Cognitive Function
  • 8.6 Overall Emotional Well-being
  • 8.7 Other End Users

9 Global Gut-Brain Axis & Mood-Enhancing FMCG Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Nestle S.A.
  • 11.2 Olipop, Inc.
  • 11.3 Danone S.A.
  • 11.4 Seed Health
  • 11.5 PepsiCo, Inc.
  • 11.6 BioGaia AB
  • 11.7 Yakult Honsha Co., Ltd.
  • 11.8 Cargill, Incorporated
  • 11.9 Abbott Laboratories
  • 11.10 General Mills, Inc.
  • 11.11 Chr. Hansen Holding A/S
  • 11.12 Unilever PLC
  • 11.13 Kerry Group plc
  • 11.14 BASF SE
  • 11.15 DuPont de Nemours, Inc.

List of Tables

  • Table 1 Global Gut-Brain Axis & Mood-Enhancing FMCG Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Gut-Brain Axis & Mood-Enhancing FMCG Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Gut-Brain Axis & Mood-Enhancing FMCG Market Outlook, By Functional Beverages (2024-2032) ($MN)
  • Table 4 Global Gut-Brain Axis & Mood-Enhancing FMCG Market Outlook, By Probiotic Drinks (2024-2032) ($MN)
  • Table 5 Global Gut-Brain Axis & Mood-Enhancing FMCG Market Outlook, By Prebiotic Drinks (2024-2032) ($MN)
  • Table 6 Global Gut-Brain Axis & Mood-Enhancing FMCG Market Outlook, By Adaptogen & Botanical Drinks (2024-2032) ($MN)
  • Table 7 Global Gut-Brain Axis & Mood-Enhancing FMCG Market Outlook, By Functional Foods (2024-2032) ($MN)
  • Table 8 Global Gut-Brain Axis & Mood-Enhancing FMCG Market Outlook, By Snack Bars (2024-2032) ($MN)
  • Table 9 Global Gut-Brain Axis & Mood-Enhancing FMCG Market Outlook, By Cereals & Breakfast Foods (2024-2032) ($MN)
  • Table 10 Global Gut-Brain Axis & Mood-Enhancing FMCG Market Outlook, By Fermented Foods (2024-2032) ($MN)
  • Table 11 Global Gut-Brain Axis & Mood-Enhancing FMCG Market Outlook, By Dietary Supplements (2024-2032) ($MN)
  • Table 12 Global Gut-Brain Axis & Mood-Enhancing FMCG Market Outlook, By Probiotics (2024-2032) ($MN)
  • Table 13 Global Gut-Brain Axis & Mood-Enhancing FMCG Market Outlook, By Prebiotics (2024-2032) ($MN)
  • Table 14 Global Gut-Brain Axis & Mood-Enhancing FMCG Market Outlook, By Synbiotics (2024-2032) ($MN)
  • Table 15 Global Gut-Brain Axis & Mood-Enhancing FMCG Market Outlook, By Mood-Targeted Nutraceuticals (2024-2032) ($MN)
  • Table 16 Global Gut-Brain Axis & Mood-Enhancing FMCG Market Outlook, By Other Product Types (2024-2032) ($MN)
  • Table 17 Global Gut-Brain Axis & Mood-Enhancing FMCG Market Outlook, By Ingredient (2024-2032) ($MN)
  • Table 18 Global Gut-Brain Axis & Mood-Enhancing FMCG Market Outlook, By Fibers (2024-2032) ($MN)
  • Table 19 Global Gut-Brain Axis & Mood-Enhancing FMCG Market Outlook, By Adaptogens & Herbal Extracts (2024-2032) ($MN)
  • Table 20 Global Gut-Brain Axis & Mood-Enhancing FMCG Market Outlook, By Amino Acids & Neuro-nutrients (2024-2032) ($MN)
  • Table 21 Global Gut-Brain Axis & Mood-Enhancing FMCG Market Outlook, By Vitamins & Minerals (2024-2032) ($MN)
  • Table 22 Global Gut-Brain Axis & Mood-Enhancing FMCG Market Outlook, By Other Ingredients (2024-2032) ($MN)
  • Table 23 Global Gut-Brain Axis & Mood-Enhancing FMCG Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 24 Global Gut-Brain Axis & Mood-Enhancing FMCG Market Outlook, By Supermarkets & Hypermarkets (2024-2032) ($MN)
  • Table 25 Global Gut-Brain Axis & Mood-Enhancing FMCG Market Outlook, By Pharmacies & Health Stores (2024-2032) ($MN)
  • Table 26 Global Gut-Brain Axis & Mood-Enhancing FMCG Market Outlook, By Online Retail (2024-2032) ($MN)
  • Table 27 Global Gut-Brain Axis & Mood-Enhancing FMCG Market Outlook, By Direct-to-Consumer Subscriptions (2024-2032) ($MN)
  • Table 28 Global Gut-Brain Axis & Mood-Enhancing FMCG Market Outlook, By Other Distribution Channels (2024-2032) ($MN)
  • Table 29 Global Gut-Brain Axis & Mood-Enhancing FMCG Market Outlook, By End User (2024-2032) ($MN)
  • Table 30 Global Gut-Brain Axis & Mood-Enhancing FMCG Market Outlook, By Digestive Health (2024-2032) ($MN)
  • Table 31 Global Gut-Brain Axis & Mood-Enhancing FMCG Market Outlook, By Stress & Anxiety Reduction (2024-2032) ($MN)
  • Table 32 Global Gut-Brain Axis & Mood-Enhancing FMCG Market Outlook, By Sleep Improvement (2024-2032) ($MN)
  • Table 33 Global Gut-Brain Axis & Mood-Enhancing FMCG Market Outlook, By Cognitive Function (2024-2032) ($MN)
  • Table 34 Global Gut-Brain Axis & Mood-Enhancing FMCG Market Outlook, By Overall Emotional Well-being (2024-2032) ($MN)
  • Table 35 Global Gut-Brain Axis & Mood-Enhancing FMCG Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.